Free Newsletter
Alzheimer's patch used to deliver vaccine to mice
In a new study, researchers used a patch to deliver an Alzheimer's vaccine to mice that spurred their immune systems to recognize beta amyloid protein and destroy it. That protein is linked to the formation of beta amyloid plaque in the brain that characterizes the memory-wasting disease. The researchers say that the decision to deliver the vaccine transdermally could help avoid incidences of inflammation and death in a study involving an injected vaccine. If a follow-up study finds that the patch can help preserve memory, the scientists will call for a human clinical trial.
"While many groups have shown vaccinating against the beta amyloid protein can reduce Alzheimer's-like pathology including certain cognitive deficits, this study is the first to demonstrate that immunization using the skin may be effective," says study leader Jun Tan of the University of South Florida department of psychiatry.
- check out the report on the Alzheimer's study from the BBC
Related Articles:
Enzyme essential to preventing Alzheimer's. Report
Researchers hopeful of Alzheimer's cure. Report
Scientists induce brain disorders in Alzheimer's mice. Report
Blood pressure meds may help prevent Alzheimer's. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: